Phase 1 trial of metronomic cyclophosphamide (CTX), bevacizumab (BV) and imatinib (IM) in patients (pts) with advanced solid tumors
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. K. Bergsland, A. H. Ko, M. A. Tempero, K. Whittaker, T. Weber, L. Fong, J. W. Park, B. M. Yeh, D. Hanahan, A. P. Venook
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2272627972
